Nonredundant role of Bax and Bak in Bid-mediated apoptosis

Pierre-François Cartron1, Philippe Juin, Lisa Oliver

  • 1INSERM U419, IFR 26, 44035 Nantes Cedex 01. Clinique Universitaire de Neurochirurgie, Hôpital G & R Laennec, CHU Nantes, 44093 Nantes Cedex 01, France.

Insights

Bax and Bak proteins are crucial for apoptosis and hindering tumor growth. In human glioblastoma, Bax deficiency is often compensated by increased Bak, severely impairing the cell death program when both are absent.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Bax and Bak are pro-apoptotic proteins critical for programmed cell death.
  • Their role in tumorigenesis suggests they can act as tumor suppressors.
  • Understanding their function in human cancers like glioblastoma is essential.

Purpose of the Study:

  • To investigate the expression and function of Bax and Bak proteins in human glioblastoma multiforme (GBM).
  • To determine the impact of Bax and Bak deficiency on GBM apoptosis and tumor growth.
  • To elucidate the differential roles of Bax and Bak in response to various apoptotic stimuli.

Main Methods:

  • Analysis of Bax and Bak protein expression in 50 human GBM tumors.
  • In vitro studies using Bax-deficient and Bax-expressing GBM cell lines.
  • Generation of Bak-deficient GBM cells using an antisense strategy.
  • Assessment of apoptosis induction by various stimuli (UV, staurosporine, doxorubicin, caspase 8, granzyme B).
  • Evaluation of tumor clonogenicity and growth in vivo.

Main Results:

  • All GBM tumors expressed Bak; three lacked Bax expression.
  • Bax-deficient GBM cells showed increased resistance to apoptosis compared to Bax-expressing cells.
  • Bak deficiency rendered cells resistant to caspase 8 but not granzyme B-induced apoptosis.
  • Complete resistance to all apoptotic stimuli was observed in cells lacking both Bax and Bak.
  • GrB-cleaved Bid and C8-cleaved Bid utilize Bax and Bak, respectively, for mitochondrial cytochrome c release.
  • Bax/Bak deficiency did not affect tumor clonogenicity or growth in mice.

Conclusions:

  • Bax deficiency in GBM is compensated by increased Bak expression.
  • Double deficiency of Bax and Bak severely impairs the apoptotic program in human cancer.
  • This study reveals the distinct roles of Bax and Bak in mediating apoptosis via different pathways.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...